Miaoshou Doctor
2
2M
2
0.33
- Areas of investment
Summary
In 2015 was created Miaoshou Doctor, which is appeared as Corporate Investor. The venture was found in Asia in China. The leading representative office of defined Corporate Investor is situated in the Beijing.
The fund was created by Tao He.
The typical case for the fund is to invest in rounds with 4 participants. The meaningful sponsors for the fund in investment in the same round are Yi Fang Group, Midas Capital, Long Hill Capital.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight VCBeat, UmerDoctor. We can highlight the next thriving fund investment areas, such as Media and Entertainment, Health Care.
The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Rounds per year
- 0.33
- Investments by industry
- Health Care (2)
- Software (1)
- Education (1)
- Internet (1)
- Media and Entertainment (1)
- Investments by region
-
- China (2)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| UmerDoctor | 25 Jan 2019 | Internet, Software, Health Care, Education | Early Stage Venture | 3M | Shanghai, Shanghai, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.